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Background: Whilst bleeding risk is assumed increased with widely used non-steroidal anti-inflammatory drugs (NSAID), the actual impact on 
serious bleeding complications in patients with atrial fibrillation (AF) is undefined. In real-life AF patients, we investigated the risk of serious bleeding 
and thromboembolism with ongoing NSAID and antithrombotic therapy.
methods: Hospitalized non-valvular AF patients 1997-2009 were identified through nationwide registries. Ongoing NSAID and concomitant 
antithrombotic therapy was determined, and the risk of bleeding and thromboembolism was assessed in adjusted Cox regression models.
results: Of 131,106 included (mean age 73.4 years, 48% female), 17,476 (13.3%) used a NSAID during a mean follow-up of 3.9 years, with 
a total of 14,193 (10.8%) and 18,274 (13.9%) events of serious bleeding and thromboembolism, respectively. Risk of serious bleeding with 
NSAIDs was doubled (HR 2.11 [2.00-2.23]) compared to no NSAID treatment, and also with concomitant antithrombotic therapy (Figure). Risk 
of thromboembolism was also increased with NSAID use (HR 1.33 [1.25-1.41]). A poorer prognosis with exposure to NSAID at time of a nonfatal 
bleeding (HR 1.09 [1.04-1.16]) or thromboembolism episode (HR 1.09 [1.00-1.18]) was observed.
conclusion: Use of NSAIDs is associated with a substantial risk of serious bleeding in AF patients, and confers no benefit on thromboembolism but 
results in harm. Physicians should exercise caution with NSAID use in AF patients.
